IOLCP (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
IOL Chemicals and Pharmaceuticals Limited |
|||
|
Price: ₹411.95 | ||
| 52 Week Low: ₹330.85 52 Week High: ₹537.70 |
|||
| Market Capital: 2,044.12 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: IOLCP Share Price Target For 2024
- 1.1.1: IOLCP Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: IOLCP Share Price Target For 2025
- 1.2.1: IOLCP Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: IOLCP Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: IOLCP Brief Company Overview
- 4: IOLCP Financial Performance
- 4.0.1: Is IOLCP A Good Buy For Long Term?
To predict the IOLCP's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
IOLCP Share Price Target For 2024
The line chart displays the monthly closing prices of IOLCP with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for IOLCP shares in 2024, see the table below.
IOLCP Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 437.41 (+6.18%) | Price Action: Aug 2023 High |
| 2024 Target 2 | 431.45 (+4.73%) | Price Action: 17 Dec 2024 High |
| 2024 Target 1 | 426.23 (+3.46%) | Price Action: Mar 2022 High |
| Current Price | 411.95 | IOLCP's share price as of 23 Dec 2024 |
| Stop Loss 1 | 405.7 (-1.52%) | Price Action: 08 Nov 2024 High |
| Stop Loss 2 | 401.0 (-2.66%) | Price Action: 01 Nov 2024 Low |
| Stop Loss 3 | 396.85 (-3.67%) | Price Action: 03 Dec 2024 High |
Short-Term Technical Outlook
Current Technical Position: IOLCP is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹393.98 serves as the nearest technical reference point.
Historical Returns: 3-month: -11.35% | 6-month: +4.18% | 1-year: -8.11%
IOLCP Share Price Target For 2025
The line chart displays the monthly closing prices of IOLCP with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for IOLCP shares in 2025, see the table below.
IOLCP Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 556.58 (+35.1%) | Price Action: Chart |
| 2025 Target 2 | 546.2 (+32.58%) | Fibonacci Extension Level 64.90% |
| 2025 Target 1 | 537.7 (+30.52%) | Fibonacci Extension Level 100.00% |
| Current Price | 411.95 | IOLCP's share price as of 23 Dec 2024 |
| Stop Loss 1 | 381.1 (-7.49%) | Price Action: 09 Dec 2024 Low |
| Stop Loss 2 | 376.1 (-8.71%) | Price Action: 10 Dec 2024 Low |
| Stop Loss 3 | 372.0 (-9.69%) | Price Action: 25 Oct 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: IOLCP is currently trading at 39.2% of its 52-week range (₹330.85 - ₹537.7).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -8.11% | 3-year: -9.85% | 5-year: +156.46%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
IOLCP Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹411.95 | ||
| 2024 | ₹471.32 | +14.41% | ₹478.39 |
| 2025 | ₹513.89 | +9.03% | ₹630.42 |
| 2026 | ₹718.49 | +39.81% | ₹794.23 |
| 2027 | ₹958.04 | +33.34% | ₹972.41 |
| 2028 | ₹1,107.60 | +15.61% | ₹1,124.21 |
| 2029 | ₹1,018.03 | -8.08% | ₹1,033.30 |
| 2030 | ₹997.72 | -1.99% | ₹1,012.69 |
| 2031 | ₹1,287.76 | +29.07% | ₹1,307.08 |
| 2032 | ₹1,613.28 | +25.27% | ₹1,637.48 |
| 2033 | ₹1,773.98 | +9.96% | ₹1,800.59 |
| 2034 | ₹1,564.74 | -11.79% | ₹1,777.09 |
| 2035 | ₹1,481.55 | -5.31% | ₹1,940.90 |
| 2036 | ₹1,857.03 | +25.34% | ₹2,107.17 |
| 2037 | ₹2,268.52 | +22.15% | ₹2,302.55 |
| 2038 | ₹2,440.35 | +7.57% | ₹2,476.96 |
| 2039 | ₹1,906.28 | -21.88% | ₹2,432.33 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
IOLCP Brief Company Overview
IOL Chemicals and Pharmaceuticals Ltd.: A Pharmaceutical and Chemical Powerhouse Key Points: Established: 1986 Headquarters: Ludhiana, India Products: Pharmaceuticals and specialty industrial chemicals IOL Chemicals and Pharmaceuticals Ltd. is a renowned manufacturer and...
supplier of pharmaceutical and chemical products in India and globally. The company has a reputable presence in the industry, known for its diverse product range and commitment to quality. Pharmaceutical Products: IOL's pharmaceutical portfolio includes active pharmaceutical ingredients (API) for various therapeutic areas, such as anti-inflammatory, anti-diabetic, and anti-convulsant medications. Some of its key API products include ibuprofen lysinate, metformin, and lamotrigine. Industrial Chemicals: The company also offers a wide range of specialty industrial chemicals, including ethyl acetate, acetyl chloride, and mono chloro acetic acid. These chemicals find applications in industries like food processing, pharmaceuticals, and chemical manufacturing.IOLCP Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,044.12 Crore | Market valuation of IOLCP's shares. |
| Revenue (TTM) | 2,071.99 Crore | Total revenue generated by IOLCP over the past twelve months. |
| Net Income (TTM) | +118.54 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +6.82% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +5.72% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-10.8% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-34.6% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
2.03 | Company's total debt divided by total shareholder equity. |
| Total Debt | 32.76 Crore | Sum of IOLCP's current & long-term financial obligations. |
| Total Cash | 115.04 Crore | Total amount of liquid funds available to IOLCP. |
| Beta | 0.88 | Beta is less than 1 indicating that the IOLCP's price is less volatile than the market. |
Is IOLCP A Good Buy For Long Term?
IOLCP, a small-cap stock with a market capitalization of ₹2,044.12 crore, shows mixed signals. While it boasts a healthy cash balance of ₹115.04 crore (Q2 2024-25) and relatively low debt (₹32.76 crore), its recent performance is concerning. A negative 34.6% change in earnings compared to the same quarter last year, coupled with a significant YTD return of -24.94%, raises red flags. Although its 5-year return is positive (109%), the past three years show a substantial loss (-53.02%). Therefore, based on current data, IOLCP is not a good buy for the long term. Further investigation is recommended before considering any investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
